Skip to main content

Table 1 Study participant characteristics

From: Rare TREM2 variants associated with Alzheimer’s disease display reduced cell surface expression

Cohort

Variable

AD

Control

P-value

Discovery (UCSF)

N

31

245

 

Age at Onset / First Visit

77.8 ± 4.5

68.5 ± 8.5

p < 0.001

Sex (M / F)

16 / 15

99 / 146

0.18

Edu (Years, Mean ± SD)

17.0 ± 3.7

17.3 ± 2.1

0.45

CDR (Mean ± SD)

0.8 ± 0.3

0.0 ± 0.1

p < 0.001

MMSE (Mean ± SD)

22.2 ± 5.3

29.4 ± 0.8

p < 0.001

APOE ε4 dose (0 / 1 / 2)

9 / 17 / 5

190 / 48 / 4

p < 0.001

# Pathological Confirmed AD

12

  

Replication (ADSP)

N

2927

2633

 

Age at Onset / First Visit

75.3 ± 8.4

85.5 ± 5.1

p < 0.001

Sex (M / F)

1299 / 1628

1185 / 1448

0.639334

Edu (Years, Mean ± SD)

NA

NA

NA

CDR (Mean ± SD)

NA

NA

NA

MMSE (Mean ± SD)

NA

NA

NA

APOE ε4 dose (0 / 1 / 2)

1660 / 1184 / 83

2239 / 386 / 8

p < 0.001

# Pathological Confirmed AD

1057

  
  1. Summary demographic, clinical, and genetic information is shown for the Discovery and Replication Cohorts. Note: three individuals in the UCSF Cohort (all controls) do not currently have APOE ε4 genotyped. M Male, F Female, Edu Education, SD Standard Deviation, MMSE Mini Mental State Examination, NA Not Available